U.S. Pharmacist eNewsletter
December 2021

ACIP Proposes New, Straightforward Pneumococcal Vaccine Recommendations
Advice on who should get pneumococcal vaccines and when has been confusing for pharmacists and others administering the vaccines. Now, a government vaccine advisory group is urging that the advice be simpler to understand. Find out what the CDC’s Advisory Committee on Immunization Practices (ACIP) is suggesting, as well as the next steps necessary to put those in place.


New FDA-Approved Hepatitis B Vaccine Expected in Early 2022
With the likelihood of expanded recommendations on use of hepatitis B vaccines, a new product has been approved by the FDA and is expected to be available early next year. A key public health advisory group recently recommended all adults aged 18 to 59 years and older with risk factors receive the vaccine. Read more.


Receipt of mRNA COVID-19 Vaccines Not Linked to Herpes Zoster Reactivation
Some published information, as well as media reports, have warned about the risk of herpes zoster reactivation in recipients of messenger RNA (mRNA) COVID-19 vaccines. Pharmacists can reassure those concerned about that side effect, however, because a new study found no link. Here are more details.

Connect With U.S. Pharmacist
Facebook Twitter USP Google AppUSP Itunes App
Advertisement Advertisement